A mediterranean age-comorbidity prognostic index for survival in dialysis populations

Journal of Nephrology

Volumn 20, Issue 6, 2007, Pages 696-702

  Lucas, Milagros Fernández ^a   Teruel, Jose Luis ^a   Zamora, Javier ^a   Mateos, Mirian López ^a   Rivera, Maite ^a   Ortuño, Joaquin ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Heart failure in dialysis patients; Ischemic heart disease in dialysis; Mediterranean age comorbidity prognostic index; Older dialysis patients

Indexed keywords

ADULT; AGE COMORBIDITY PROGNOSTIC INDEX; AGE DISTRIBUTION; AGED; ARTICLE; COMORBIDITY; DISEASE FREE SURVIVAL; FEMALE; HEART FAILURE; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RATING SCALE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIALYSIS; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIFE TABLES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 39449129589     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative data-bases. Int J Epidemiol 2000; 29: 891-8.
2. Wright LF. Survival in patients with end-stage renal disease. Am J Kidney Dis 1991; 17: 25-8.
3. Khan IH, Catto GD, Edward N, Fleming LW, Henderson IS, Macleod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993; 341: 415-8.
4. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987; 40: 373-83.
5. Charlson ME, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-51.
6. Hemmelgarn BR, Manns BJ, Hude Quan MS, Ghali WA. Adapting the Charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis 2003; 42: 125-32.
7. US Renal Data System. USRDS 2001 annual data report. Bethesda, MD (USA): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2001.
8. Mailloux LU, Napolitano B, Bellucci AG, Mossey RT, Venance MA, Wilkes BM. The impact of co-morbid risk factors at the start of dialysis upon the survival of ESRD patients. ASAIO J 1996; 42: 164-9.
9. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H, et al. Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 1992; 19: 214-34.
10. Keane WF, Collins AJ. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 1994; 24: 1010-8.
11. Nicolucci A, Cubasso D, Labbrozzi D, Mari E, Impicciatore P, Procaccini DA, Forcella M, Stella I, Querques M, Pappani A, et al. Effect of coexistent diseases on survival of patients undergoing dialysis. ASAIO J 1992; 38: M291-5.
12. Soucie JM, McClellan WN. Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J Am Soc Nephrol 1996; 7: 2169-75.
13. Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ 1999; 318: 217-23.
14. Davis SJ, Russell L, Bryan J, Phillips P, Russell GI. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: Their interrelationship and prediction of survival. Am J Kidney Dis 1995; 26: 353-61.
15. Miskulin DC, Athienites NV, Yan G, Martin AA, Ornt DB, Kusek JW, Meyer KB, Levey AS; for the Hemodialysis (HEMO) Study Group. Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int 2001; 60: 1498-510.
16. Fried L, Bernardini J, Piraino B. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 337-42.
17. Van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PMM, Krediet RT; for the NECOSAD Study Group. How to adjust for comorbidity in survival studies in ESRD patients: A comparison of different indices. Am J Kidney Dis 2002; 40: 82-9.
18. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-87.
19. Hutchinson TA, Thomas DC, MacGibbon B. Predicting survival in adults with end-stage renal disease: An age equivalence index. Ann Intern Med 1982; 96: 417-23.
20. Wallen MD, Radhakrishnan J, Appel G, Hodgson ME, Pablos-Mendez A. An analysis of cardiac mortality in patients with new-onset end-stage renal disease in New York State. Clin Nephrol 2001; 55: 101-8.
21. London GM, Marchais SJ, Guerin AP, Metivier F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 2005; 14: 525-31.
22. Fernandez Lucas M, Quereda C, Teruel JL, Orte L, Marcen R, Ortuño J. Effect of hypertension before beginning dialysis on survival of hemodialysis patients. Am J Kidney Dis 2003; 41: 814-21.